Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MANE compared with ZURA: revenue, margins and what each company keeps, and the suppliers and customers both name
MANE
Veradermics, Inc
Change
Mkt cap
Revenue
Revenue
ZURA
Zura Bio Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
MANE
Veradermics, Inc
vs
ZURA
Zura Bio Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
MANE: latest quarter not drawable. ZURA: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MANE
1
—
Therapeutics
unlisted
supplier
Shared
0
No shared counterparties.
Only ZURA
2
LLY
Eli Lilly
supplier
PFE
Pfizer
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MANE, solid
ZURA, dashed
MANE
Veradermics, Inc
Change
133.59
▼
−4.37%
Mkt cap
$5.6B
ZURA
Zura Bio Ltd
Change
3.92
▼
−2.97%
Regular session
Nov 2 '26
Mkt cap
$516.0M
vs
Compare
Regular session
Nov 2 '26
MANE
Veradermics, Inc
vs
ZURA
Zura Bio Ltd
133.59
▼
−4.37%
Price
3.92
▼
−2.97%
$5.6B
Mkt cap
$516.0M
Change
Change
MANE
133.59
▼
−4.37%
vs
ZURA
3.92
▼
−2.97%
Regular session
Nov 2 '26